EMVision Medical Devices Ltd (ASX:EMV)

Australia flag Australia · Delayed Price · Currency is AUD
1.805
+0.075 (4.34%)
Jul 25, 2025, 3:47 PM AEST
-10.64%
Market Cap154.36M
Revenue (ttm)8.06M
Net Income (ttm)-6.19M
Shares Out85.52M
EPS (ttm)-0.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume43,197
Average Volume21,358
Open1.780
Previous Close1.730
Day's Range1.750 - 1.810
52-Week Range1.630 - 2.350
Beta0.84
RSI59.09
Earnings DateAug 28, 2025

About EMVision Medical Devices

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia. [Read more]

Sector Healthcare
Founded 2017
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol EMV
Full Company Profile

Financial Performance

In 2024, EMVision Medical Devices's revenue was 11.22 million, an increase of 60.89% compared to the previous year's 6.97 million. Losses were -2.73 million, -29.48% less than in 2023.

Financial Statements

News

There is no news available yet.